OVCA2 Antikörper (AA 11-100)
Kurzübersicht für OVCA2 Antikörper (AA 11-100) (ABIN717071)
Target
Alle OVCA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 11-100
-
Kreuzreaktivität
- Ratte
-
Homologie
- Human,Mouse,Dog,Cow,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human OVCA2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- OVCA2 (Ovarian Tumor Suppressor Candidate 2 (OVCA2))
-
Andere Bezeichnung
- Ovca2
-
Hintergrund
-
Synonyms: Candidate tumor suppressor in ovarian cancer 2, Candidate tumor suppressor OVCA2, ovarian cancer associated gene 2 protein, Ovarian cancer gene 2 protein, ovarian tumor suppressor candidate 2, OVCA2_HUMAN.
Background: Ubiquitously expressed protein which belongs to the UPF0483 (OVCA2) family. Encoded in an intron of the gene DPH1/OVCA1 (same strand).
Target
-